ArticleFrontiers in psychology2025
Correlation between cortical morphology and synaptic-associated proteins levels in poststroke aphasia: a pilot study.
Article in Frontiers in psychology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Poststroke aphasia (PSA) is a leading cause of poststroke disability. The neurobiological mechanisms mediating early recovery, however, remain incompletely characterized-particularly how serum levels of key synaptic proteins correlate with neuroimaging measures of cortical integrity and collectively contribute to language outcomes. This study was therefore designed to examine the relationships between these circulating synaptic markers and structural alterations in the brain of PSA patients to elucidate the potential mechanisms underlying functional recovery. Methods: A total of 12 PSA patients and 12 healthy controls (HCs) were enrolled in this prospective study. Serum levels of synaptic-associated proteins were measured, and high-resolution 3T structural magnetic resonance imaging (MRI) was performed. Group differences in brain structure were analyzed using voxel-based morphometry (VBM) and surface-based morphometry (SBM). Correlation analysis was conducted among factors with significant group differences. Results: Compared with HCs, PSA patients had significantly altered serum levels of Conclusion: In summary, patients with PSA exhibit distinct alterations in synaptic protein expression accompanied by widespread gray matter atrophy, marked by reduced GMV, CT, and SULC, particularly in language-related regions. These structural and molecular interrelationships suggest that early recovery involves neuroplastic mechanisms, potentially mediated via synaptic plasticity as well as structural adaptation. Our findings provide novel multidimensional insights into the neurobiological substrate of PSA and highlight promising pathways for future mechanistic and therapeutic research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.